0 items USD 0.00Search
- Did you mean
- antibody-oligonucleotide conjugate
Your search for "Antibody-Oligonucleotide Conjugates" gave back 10742 results.
The global Mylotarg market size was valued at US$ 209.6 million in 2023. With growing demand in downstream market, the Mylotarg is forecast to a...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
The global market for Anti-HER2 Therapy was valued at US$ 6160 million in the year 2024 and is projected to reach a revised size of US$ 8346 million...
颁补迟补濒辞驳:听
MRRPB5
March 2025
Price: USD 2,900.00
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
The global Acute Lymphocytic Leukemia (ALL) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
颁补迟补濒辞驳:听
MRRPB5
July 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
The global Gemtuzumab Ozogamicin market size was valued at US$ 209.6 million in 2023. With growing demand in downstream market, the Gemtuzumab...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
颁补迟补濒辞驳:听
La Merie Publishing
January 2018
Price: USD 2,800.00
The global market for Acute Lymphocytic Leukemia (ALL) Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
The global Small Molecule Targeted Cancer Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to...
颁补迟补濒辞驳:听
LPI
February 2025
Price: USD 3,660.00
The global market for Small Molecule Targeted Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of...
颁补迟补濒辞驳:听
MRRPB5
January 2025
Price: USD 2,900.00
The increasing popularity of biologics in medicine has led to a significant rise in outsourcing manufacturing. Biologics contract manufacturers have...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
听
